Login / Signup

Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.

Long ChenKai HuCheng ChengQuanman HuLiang ZhangTongyan AnYongjun GuoShuaiyin ChenGuangcai Duan
Published in: International journal of colorectal disease (2022)
COVID-19 patients with IBD had an increased risk of adverse outcomes than those without IBD, whereas anti-TNF treatment might reduce the risk.
Keyphrases
  • sars cov
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • rheumatoid arthritis
  • prognostic factors
  • respiratory syndrome coronavirus
  • ulcerative colitis
  • coronavirus disease